A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer
Prachi Walke, Jared D. W. Price, Frederick S. Vizeacoumar, Nickson Joseph, Vincent Maranda, Bari Chowdhury, Jay Patel, Yue Zhang, He Dong, Lara New, Ashtalakshmi Ganapathysamy, Li Hui Gong, Mary Lazell-Wright, Hussain Elhasasna, Kalpana Kalyanasundaram Bhanumathy, , Franco J. Vizeacoumar
This study identifies Neurog2 as a potential therapeutic target for MYCN-driven neuroendocrine prostate cancer by showing its role in promoting tumor growth and NEPC development.
Oncogene · Apr 29, 2025Peer-reviewedCancer Biology